Literature DB >> 12123824

Stress-induced premature senescence in BJ and hTERT-BJ1 human foreskin fibroblasts.

João Pedro de Magalhães1, Florence Chainiaux, José Remacle, Olivier Toussaint.   

Abstract

To test the involvement of the telomeres in the senescent phenotype, we used telomerase-immortalized human foreskin fibroblasts (hTERT-BJ1). We exposed hTERT-BJ1 and parental BJ cells to either UVB or H(2)O(2) subcytotoxic stress(es). Both cell lines developed biomarkers of replicative senescence: loss of replicative potential, increase in senescence-associated beta-galactosidase activity, typical senescence-like morphology, overexpression of p21(WAF-1) and p16(INK-4a), and decreased level of the hyperphosphorylated form of pRb. Telomere shortening was slightly higher under stress for both BJ and hTERT-BJ1 but still much lower than that reported for other cell lines. We conclude that pathways alternative to telomere shortening must cause the appearance of the senescence phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12123824     DOI: 10.1016/s0014-5793(02)02973-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Hormesis-based anti-aging products: a case study of a novel cosmetic.

Authors:  Suresh I S Rattan; Valérie Kryzch; Sylvianne Schnebert; Eric Perrier; Carine Nizard
Journal:  Dose Response       Date:  2012-01-12       Impact factor: 2.658

2.  Increasing the complexity of respiratory syncytial virus infection: Reactive oxygen species, DNA damage, and premature senescence.

Authors:  Patrick Dumont
Journal:  Virulence       Date:  2016-03-23       Impact factor: 5.882

3.  cGAS is essential for cellular senescence.

Authors:  Hui Yang; Hanze Wang; Junyao Ren; Qi Chen; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

4.  Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.

Authors:  Daina Z Ewton; Jing Hu; Maria Vilenchik; Xiaobing Deng; Kin-Chun Luk; Ann Polonskaia; Ann F Hoffman; Karen Zipf; John F Boylan; Eileen A Friedman
Journal:  Mol Cancer Ther       Date:  2011-08-30       Impact factor: 6.261

5.  Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.

Authors:  Tomer Avraham; Alan Yan; Jamie C Zampell; Sanjay V Daluvoy; Adriana Haimovitz-Friedman; Andrew P Cordeiro; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-02       Impact factor: 4.249

6.  gamma-Tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals.

Authors:  Suzana Makpol; Azrina Zainal Abidin; Khalilah Sairin; Musalmah Mazlan; Gapor Md Top; Wan Zurinah Wan Ngah
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

7.  SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis.

Authors:  Dhanoop Manikoth Ayyathan; Praveen Koganti; Victoria Marcu-Malina; Talia Litmanovitch; Luba Trakhtenbrot; Andrea Emanuelli; Liat Apel-Sarid; Michael Blank
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

Review 8.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.

Authors:  Ibrahim Y Abdelgawad; Karim T Sadak; Diana W Lone; Mohamed S Dabour; Laura J Niedernhofer; Beshay N Zordoky
Journal:  Pharmacol Ther       Date:  2020-12-01       Impact factor: 12.310

9.  Role of mitochondrial translocation of telomerase in hepatocellular carcinoma cells with multidrug resistance.

Authors:  Xianlong Ling; Lei Wen; Yuan Zhou
Journal:  Int J Med Sci       Date:  2012-08-30       Impact factor: 3.738

10.  An analysis and validation pipeline for large-scale RNAi-based screens.

Authors:  Michael Plank; Guang Hu; A Sofia Silva; Shona H Wood; Emily E Hesketh; Georges Janssens; André Macedo; João Pedro de Magalhães; George M Church
Journal:  Sci Rep       Date:  2013-01-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.